Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for CheckMate 592 is displayed, with details about the nivolumab–ipilimumab study, participation criteria, study locations, and measured outcomes.
    Difference
    66%
    Check dated 2026-11-11T01:21:05.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:37:16.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:24:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:12:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previously visible study record details for the trial and offering a Home link instead.
    Difference
    18%
    Check dated 2026-09-23T00:52:35.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated version of the study page document.
    Difference
    0.0%
    Check dated 2026-09-15T23:38:48.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.